The TβRII expression rate was significantly increased in patients with lymph node metastasis compared to those without lymph node metastasis (67.40% vs 46.8%; P = 0.033). The gene discussed is TGFBR2; the disease is metastatic malignant neoplasm in the lymph nodes.